Dilated cardiomyopathies and non-compaction cardiomyopathy
Authors:
Open Access
- 27 February 2020
- journal article
- research article
- Published by Springer Nature in Herz
- Vol. 45 (3) , 212-220
Abstract
Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy and one of the most common causes of heart failure. It is characterized by left or biventricular dilation and a reduced systolic function. The causes are manifold and range from myocarditis to alcohol and other toxins, to rheumatological, endocrinological, and metabolic diseases. Peripartum cardiomyopathy is a special form that occurs at the end of or shortly after pregnancy. Genetic mutations can be detected in approximately 30–50% of DCM patients. Owing to the growing possibilities of genetic diagnostics, increasingly more triggering variants and hereditary mechanisms emerge. This is particularly important with regard to risk stratification for patients with variants with an increased risk of arrhythmias. Patient prognosis is determined by the occurrence of heart failure and arrhythmias. In addition to the treatment of the underlying disease or the elimination of triggering harmful toxins, therapy consists in guideline-directed heart failure treatment including drug and device therapy.Keywords
This publication has 63 references indexed in Scilit:
- Truncations of Titin Causing Dilated CardiomyopathyNew England Journal of Medicine, 2012
- LMNA cardiomyopathy: cell biology and genetics meet clinical medicineDisease Models & Mechanisms, 2011
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and CardiomyopathiesHeart Rhythm, 2011
- Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical PracticeCirculation, 2011
- Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?European Heart Journal, 2011
- Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal, 2010
- Identification of Novel Mutations in RBM20 in Patients with Dilated CardiomyopathyClinical and Translational Science, 2010
- Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathyAmerican Heart Journal, 2008
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980